Cc1nnc(N2CCC(C(=O)NC3CCC(C)CC3)CC2)c2nn(-c3ccc(Cl)cc3)c(C)c12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?